Objective: To assess the efficacy of reducing the duration of intrauterine balloons placement from 12 h to 6 h for labor induction, specifically in terms of reducing the time from balloon placement to delivery and the rate of cesarean delivery.
Methods: Comprehensive searches were conducted across the Cochrane Library, Web of Science, PubMed, ClinicalTrials.gov, and Embase from their inception until August 2024. Randomized controlled trials (RCTs) incorporated into our meta-analysis involved nulliparous and multiparous women with an unfavorable cervix requiring labor induction, where the intervention was intrauterine balloon placement for 6 h, compared with the placement for 12 h, and the outcomes included the time from balloon placement to delivery, the rate of cesarean delivery, and maternal and neonatal adverse outcomes. The Cochrane risk-of-bias assessment tool was used to appraise the quality of the studies incorporated in our analysis. The meta-analysis was executed using RevMan 5.3 statistical software. Heterogeneity among the selected studies was assessed using the I statistic. Dichotomous outcomes were expressed as relative risk (RR) with corresponding 95% confidence intervals (CI), while continuous outcomes were represented as the mean difference (MD).
Results: A total of six studies, encompassing a total of 1,160 nulliparous and multiparous women with an unfavorable cervix, were incorporated into the systematic review. In comparison to the 12-hours groups, women in 6-hours group experienced a significantly shorter interval from intrauterine balloon placement to delivery (MD = -3.67, 95 %CI: -4.73, -2.62, P<0.00001), and a reduced rate of cesarean delivery (RR = 0.83, 95 %CI: 0.71, 0.98, P = 0.02). Additionally, no statistically significant differences were noted in maternal and neonatal adverse outcomes between the two groups.
Conclusions: These findings substantiate the potential benefits of reducing the duration of intrauterine balloons usage from 12 to 6 h during labor induction.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ejogrb.2025.03.007 | DOI Listing |
J Spec Oper Med
March 2025
Ukrainian Military Medical Service.
The Russo-Ukrainian war's prolonged warfare, resource constraints, and extended evacuation times have forced significant adaptations in Ukraine's medical system - including technological advancements and strategic resource placement. This study examined if the Abdominal Aortic and Junctional Tourniquet - Stabilized (AAJT-S) could manage traumatic cardiac arrest (TCA) at forward surgical stabilization sites (FSSS) as an adjunct to damage control surgery. Six patients in severe hypovolemic shock presented at an FSSS during fighting in Bakhmut (July 2022) and Slovyansk (May 2023).
View Article and Find Full Text PDFEur J Obstet Gynecol Reprod Biol
March 2025
Department of Gynaecology and Obstetrics, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou 324000, China.
Objective: To assess the efficacy of reducing the duration of intrauterine balloons placement from 12 h to 6 h for labor induction, specifically in terms of reducing the time from balloon placement to delivery and the rate of cesarean delivery.
Methods: Comprehensive searches were conducted across the Cochrane Library, Web of Science, PubMed, ClinicalTrials.gov, and Embase from their inception until August 2024.
J Extra Corpor Technol
March 2025
Department of Anesthesiology, Boston Medical Center, 750 Albany Street, Floor 2R, Power Plant Building, Boston, MA 02118, USA.
Background: Venoarterial Extracorporeal Membrane Oxygenation (VA-ECMO) is a means of supporting the lungs or the heart and lungs in patients with hemodynamic compromise that is refractory to conventional measures. VA-ECMO is most commonly deployed in a percutaneous fashion with femoral arterial and venous access. While VA-ECMO, particularly in a femoral-femoral configuration, provides both hemodynamic and ventilatory support, it also causes increased afterload on the left ventricle (LV) which in turn may result in LV distension (LVD).
View Article and Find Full Text PDFJHEP Rep
March 2025
Gastroenterology, Department of Surgery, Oncology and Gastroenterology, Padova University Hospital, Padova, Italy, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN-Liver), Italy.
Background & Aims: There is a lack of consensus on the optimal management of fundal gastric varices (GVs) in patients with cirrhosis due to varied anatomy and hemodynamics. In this study, we evaluate the safety and efficacy of trans-splenic anterograde coil-assisted transvenous occlusion (TACATO) for preventing recurrent bleeding in fundal GVs associated with gastrorenal shunt (GRS).
Methods: In this 4-year study, patients with cirrhosis with GRS-associated GV bleeding, without prior esophageal variceal bleeding, ascites, or portal vein thrombosis, were eligible for TACATO.
JACC Cardiovasc Interv
February 2025
Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, USA.
Background: Short-term clinical outcomes after transcatheter aortic valve replacement (TAVR) are similar in individuals with small or large annuli. The longer term impact of prosthesis-patient mismatch (PPM) and mean gradient (MG) post-TAVR in these patients remains controversial.
Objectives: The aim of this study was to investigate 5-year outcomes in patients with small vs large annuli.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!